After 28 days of implantation, 10 out of 10 immunodeficient mice injected with H460 first-sphere cells overexpressing ZNF322A (500 cells) bore large tumor burden, whereas 5 out of 10 formed small tumors in vector control sphere cells (Fig. 2f). Here, ZNF322 is linked to neoplasm.